Researchers at the University of California, San Diego School of Medicine, report that an antibody therapy already in clinical trials to treat Chronic Lymphocytic Leukaemia (CLL) may also be used to treat ovarian cancer and likely other cancers as well, in a study published in the Nov. 17 online early edition of the iProceedings of the National Academy of Sciences/i (iPNAS/i). The findings extend the anti-cancer potential of an experimental monoclonal antibody ...
via Medindia Health News More READ
via Medindia Health News More READ
No comments:
Post a Comment